1[1]Cosmi B,Hirsh J.Low Molecular Weight Heparins[J].Current Opinion in Cardiology,1994,9(5):612
2[2]Stamatakis JD,Kakkar V,Lawrence D,et al.Femoral vein thrombosis and hip replacement[J].Bt Med J,1997,2(6081):223
3[3]Morris D,Kerstein.Thrombophlebitis and anticoagulation:studies relating to duration of anticoagulation,low molecular weight heparin in prophylaxis,and thrombophlebitis by low molecular weight heparin in the home care setting[J].Current Surgery,1998,55(5):183
4[4]Kakkar V,Boeckl O,Boneu B,et al.Efficacy and safety of a low molecular weight heparin and unfractionated heparin for prophylaxis of postoperative venous thromboembolism:European multicenter trial[J].World J Surg,1997,21(1):2
5Joynt GM, Kew J, Gomersall CD, et al. Deep venous thrombosis- caused by femoral venous catheters in critically ill adult patients[J]. Chest, 2000, 117(1): 178-183.
6Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous throm- boembolism: The Seventh ACCP oonforence on antithrom, boric and thrombolytic therapy[J]. Chest, 2004, 126(3 ,Suppl): 338-400.
7K.her A, Samama MM. Prmary and secondary prophylaxis of venous thromboembolism with low-molecular-weisat heparins.prolongedthromboprophy laxis,an ahematlve to vitamin Kantagonista [J]. Thromb Haemost, 2005, 3(3): 473-481.
8Kenneth A Bauer,Frists R.Rosedoal,John A.Heit Hypercoagu lability:Too Many Tests,Too Much Conflicting Data.Hematology,2002.353-368
9Chunital S D,Glinsberg J S.Strategies for the diagnosis of deep veim thrombosis and pulmonary embolism. Thrombosis Reserch, 2000,97:33
10Litin S C,Heit J A,Mees K A.Use of low-molecular weight heparin in the treament of venous thrombocmbdic disease:answers to frequently asked questions.MayoClin-Proc,1998,73(6):545
